Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04839380
Status:
COMPLETED
Last Update Posted:
2023-10-31
First Post:
2021-04-08
Brief Title:
The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Study Overview
Official Title:
An Open-Label Single-Arm Study to Evaluate the Effect of Ruxolitinib 15 Cream on Itch in Adult Participants With Atopic Dermatitis
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SCRATCH-AD
Brief Summary:
The purpose of the study is to evaluate the effect of ruxolitinib cream on itch in participants with Atopic Dermatitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None